These findings provide novel insights into the role of Gal-9 and its regulation by IL-27 in CLL, suggesting a mechanistic link between increased Gal-9 expression, immunosuppressive microenvironment modulation, and disease progression. The gene discussed is LGALS9; the disease is B-cell chronic lymphocytic leukemia.